Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

Share Price is delayed by 15 minutes
Get Live Data
4,401.50    117.00 (2.73%)
Bid:
4,382.00
Ask:
4,383.50
Spread: 1.50 (0.034%)
Market Cap: £95.31b
ULVR Live PriceLast checked at - London Stock Exchange

Intraday Unilever Share Chart

Transaction in Own Shares

11 Apr 2023 17:05

RNS Number : 8746V
Unilever PLC
11 April 2023
 

TRANSACTIONS IN OWN SECURITIES

 

 

11 April 2023

 

Unilever PLC (the "Company") announces today that it has purchased the following number of its ordinary shares on the London Stock Exchange from EXANE SA having its registered office at 6, rue Ménars 75002 Paris, France, with Commercial registration number 342 040 268 RCS Paris ("the Broker"). The repurchased shares will be held in treasury.

 

Ordinary Shares

 

Date of purchases:

 

11 April 2023

Number of ordinary shares purchased:

 

2,040

Highest price paid per share:

 

GBp 4,305.00

Lowest price paid per share:

 

GBp 4,275.00

Volume weighted average price paid per share:

GBp 4,294.29

 

Such purchases form part of the Company's existing share buy-back programme and were effected pursuant to the instructions issued to the Broker by the Company on 17 March 2023, as announced on that date.

 

Following the purchase of these shares, Unilever holds 102,356,670 of its ordinary shares in treasury and has 2,526,937,102 ordinary shares in issue (excluding treasury shares).

 

Aggregated information

 

Trading venue

Volume weighted average price (GBp)

Aggregated volume

LSE

4,295.06

1,905

CBOE BXE

CBOE CXE

4,276.25

90

Turquoise

4,297.48

45

 

 

Media Enquires:

Please contact the Unilever Press Office at: Press-Office.London@Unilever.com

 

Transaction details

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual trades made by the Broker on behalf of the Company as part of the buy-back programme is detailed below:

 

Quantity bought

Price (GBp)

Trading Venue

Time (BST)

227

4,305.00

LSE

08:04:17

85

4,275.00

CBOE CXE

08:47:43

156

4,275.00

LSE

08:47:43

5

4,289.50

LSE

09:56:46

145

4,289.50

LSE

09:56:46

198

4,300.00

LSE

10:54:50

205

4,293.50

LSE

11:53:59

5

4,294.00

LSE

13:28:24

190

4,294.00

LSE

13:28:24

14

4,294.00

LSE

13:28:24

217

4,298.00

LSE

14:20:28

221

4,293.50

LSE

15:00:00

166

4,299.50

LSE

15:31:33

70

4,298.00

LSE

15:56:11

86

4,295.50

LSE

16:09:40

2

4,297.00

Turquoise

16:13:23

5

4,297.50

CBOE CXE

16:14:19

43

4,297.50

Turquoise

16:14:19

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSGZGMDVMDGFZM
Date   Source Headline
10th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20266:17 pmRNSCompletion of 2026 Share Buyback
3rd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20265:13 pmRNSTotal Voting Rights
1st Jun 202610:37 amRNSDirector/PDMR Shareholding
1st Jun 202610:29 amRNSTotal Voting Rights
27th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTransaction in Own Shares
18th May 20264:35 pmRNSDirector/PDMR Shareholding
15th May 20265:45 pmRNSPublication of Information Memorandum
15th May 20265:07 pmRNSPublication of UFN Financial Statements
13th May 20263:54 pmRNSResult of AGM
13th May 20267:00 amRNSTransaction in Own Shares
6th May 20265:49 pmRNSDirector/PDMR Shareholding
6th May 20267:00 amRNSDirector/PDMR Shareholding
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20263:08 pmRNSTotal Voting Rights
30th Apr 20267:01 amRNSShare Buy-Back Programme
30th Apr 20267:00 amRNSQ1 2026 Trading Statement
20th Apr 20261:58 pmRNSDirector/PDMR Shareholding
1st Apr 20264:42 pmRNSTotal Voting Rights
31st Mar 20263:00 pmRNSNotice of AGM
31st Mar 20261:00 pmRNSUnilever Foods and McCormick Agreement
31st Mar 20267:00 amRNSResponse to Media Speculation
20th Mar 20267:00 amRNSResponse to media speculation
6th Mar 20264:21 pmRNSDirector/PDMR Shareholding
6th Mar 20264:09 pmRNSPortfolio Update
2nd Mar 20265:50 pmRNSTotal Voting Rights
2nd Mar 20267:00 amRNSGroup Company Secretary Change
19th Feb 20267:00 amRNSDirector/PDMR Shareholding
16th Feb 20264:38 pmRNSDirector/PDMR Shareholding
16th Feb 20264:26 pmRNSDirector/PDMR Shareholding
13th Feb 20264:57 pmRNSDirector Declaration
12th Feb 20265:11 pmRNSPublication of Supplement
12th Feb 20267:00 amRNS2025 Full Year Results
5th Feb 20264:06 pmRNSNotification of issuance of equity securities
2nd Feb 20264:14 pmRNSTotal Voting Rights
8th Jan 202610:17 amRNSTotal Voting Rights
2nd Jan 20265:21 pmRNSTotal Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20257:00 amRNSCancellation of Treasury Shares
10th Dec 202511:29 amRNSDirector/PDMR Shareholding
8th Dec 20255:51 pmRNSUpdate on Share Consolidation
8th Dec 20257:00 amRNSCompletion of demerger of Ice Cream Business
5th Dec 20257:00 amRNSDemerger of Unilever’s Ice Cream Business
3rd Dec 20252:50 pmRNSCancellation of Treasury Shares
1st Dec 20256:22 pmRNSTotal Voting Rights
19th Nov 202512:23 pmRNSDirector/PDMR Shareholding
12th Nov 20257:00 amRNSDirector/PDMR Shareholding
4th Nov 20256:21 pmRNSUpdate on Demerger & Share Consolidation Timetable

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.